Werewolf Therapeutics Explores Strategic Alternatives to Maximize Stockholder Value

martes, 24 de febrero de 2026, 5:29 pm ET1 min de lectura
HOWL--

Werewolf Therapeutics is exploring strategic alternatives to advance its immune-stimulating platform and pipeline for cancer treatment. The company has engaged Piper Sandler & Co. as its exclusive financial advisor and aims to maximize shareholder value. The strategic evaluation process will consider various options, including partnerships, licensing agreements, and potential acquisitions.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios